About Erick Berglund
Form D filings for Intrommune Therapeutics from 2018 to 2024 list Erick Berglund as director.
Erick Berglund first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Erick Berglund in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Erick Berglund works with at each company, as listed on that company's latest Form D.
Intrommune Therapeutics, Inc. · Form D, Jan 22, 2024
HP
Hemanshu Pandya
Director
JR
Jonathan Rich
Director
MN
Michael Nelson
President and director
WR
William Reisacher
Director